UCB Opens Applications for the 2026 Myasthenia Gravis Scholarship to Empower Individuals

UCB Opens Applications for 2026 Myasthenia Gravis Scholarship

In a significant initiative aimed at supporting individuals affected by Myasthenia Gravis (MG), UCB, a leading global biopharmaceutical company, has officially opened applications for the second annual UCB U.S. Myasthenia Gravis Scholarship™. This scholarship is specifically designed for patients, caregivers, and family members directly impacted by MG, enabling them to pursue further education and professional development.

Scholarship Details

The scholarship offers financial assistance to help recipients achieve their educational goals, whether they are continuing education, pursuing an undergraduate or graduate degree, or seeking skills enhancement through vocational programs. This year, UCB will award 15 scholarships, with applications being accepted until January 31, 2026.

"The UCB U.S. Myasthenia Gravis Scholarship™ is dedicated to supporting those impacted by myasthenia gravis. It's one of the many ways UCB strives to empower patients and caregivers beyond the realm of medicine," stated Kimberly Moran, PhD, MBA, Senior Vice President and Head of U.S. Rare Diseases at UCB.

In its inaugural year, the scholarship program provided vital support that helped recipients surmount financial hurdles while exploring diverse educational paths.

Inspiring Stories from Scholars

Among the scholarship recipients is Deanna C., who plans to study American Sign Language at the University of New Hampshire, inspired by her four-year-old daughter who is deaf. Deanna expressed how the scholarship represents more than just monetary aid; it’s a commitment to advocacy and raising awareness for MG. "This scholarship is more than financial support. It's a symbol of the work that still needs to be done. Advocacy is no longer something I do. It's who I am," she shared.

Another recipient, Deric S., noted the profound impact the scholarship had on his educational journey. He emphasized the freedom it grants him from financial stress while completing his Master's in Public Administration. "This scholarship is actually going to take care of the rest of my Master's program, so that's a financial burden that I don't have to worry about. It's a really good feeling to know that you have people supporting you in your endeavors," he said.

How to Apply

To apply for the UCB Myasthenia Gravis Scholarship or to gather further information regarding eligibility and requirements, individuals can visit www.UCBMGscholarship.com. UCB seeks to motivate and support as many individuals as possible, providing a platform for growth and the pursuit of educational aspirations.

UCB, headquartered in Brussels, Belgium, continues its commitment to developing innovative medicines and solutions that dramatically improve the lives of those affected by severe diseases, particularly in the fields of immunology and neurology. The company employs around 9,000 professionals across 40 countries and reported revenue of €6.15 billion in 2024. For more information, visit UCB's official website or their Twitter @UCB_news.

Conclusion

As the deadline for scholarship applications approaches, UCB invites all eligible candidates to seize this opportunity. The scholarship not only alleviates financial burdens but also plays a pivotal role in fostering a sense of community and support among those affected by myasthenia gravis. As UCB aims to bridge the gap in education and personal development for these individuals, the impact of this scholarship will continue to resonate in their lives and communities.

This initiative underscores UCB's commitment not only to healthcare but also to enhancing the quality of life for those living with chronic conditions, inspiring hope and empowerment for a brighter future.